May 2005 · Vol. 17, No. 5Minimally invasive surgery in ovarian cancer
Laparoscopy has dramatically altered management of many gynecologic malignancies, but its utility in ovarian cancer has been limited—until now.
|
Fast Track
In our study, 19% of women with previous nongynecologic cancer and a new adnexal mass had a malignancy
To deter port-site recurrences:
20% to to 30% of cases are upstaged after surgical staging for presumed stage I disease
Complete laparoscopic staging can be done safely, with low morbidity, accurate findings, and adequate node counts
In some cases, intraoperative cyst rupture warrants upstaging from FIGO stage IA to IC and necessitates chemotherapy that could have been avoided
Second-look laparoscopy’s safety and accuracy are comparable to those of laparotomy, with less morbidity
|
|
Nadeem
Abu-Rustum,
MDDirector, Minimally Invasive Surgery Director, Resident and Medical Student Education Gynecology Service Memorial Sloan-Kettering Cancer Center,
New York City Susannah
Mourton,
MDFellow, Pelvic Reconstruction Group Department of Surgery Memorial Sloan-Kettering Cancer Center,
New York City
Maria’ case
she wants laparoscopy. yes or no?
|
